Skip to Main Content
Yale School of Medicine
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Yale School of Medicine
/
FIB-SEM Collaboration Core (F-SCC)
MENU
Yale School of Medicine
MENU
FIB-SEM Collaboration Core (F-SCC)
Collaborations
News
People
Publications
Discoveries
YSM Home
INFORMATION FOR
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Popular Links
Search
11 results
Refine
People (19230)
Web Pages (12542)
Documents (6941)
News (52985)
Events (27576)
Media (2878)
Clinical Trials (641)
Gender
Male (0)
Female (0)
Accept Healthy Volunteers
Yes (0)
No (0)
Categories
Addictive Behavior (0)
Aging (0)
Alcohol Addiction (0)
Alzheimer's (0)
Arthritis (0)
Asthma (0)
Autism (0)
Blood Disorders (0)
Brain & Spinal Cord & Nervous System (0)
Cancer (11)
Bladder (0)
Brain (0)
Breast (0)
Colorectal (0)
Gynecological (0)
Head and Neck (0)
Kidney (0)
Leukemia (0)
Liver (0)
Lung (10)
Lymphoma (0)
Melanoma (0)
Myeloma (0)
Non-Therapeutic (0)
Other Cancers (0)
Pancreas (0)
Pediatric Cancers (0)
Phase 1 (0)
Prevention (0)
Prostate (1)
Sarcoma (0)
Stomach and Esophagus (0)
Supportive Care (0)
Thyroid (0)
Children Health (0)
COVID-19 (0)
Diabetes (0)
Digestive System (0)
Diseases of the Respiratory Systems (0)
Endocrine System (0)
Genetics (0)
Headaches (0)
Hearing/Ear (0)
Heart/Cardiovascular (0)
Hepatitis (0)
HIV/AIDS (0)
Immune System (0)
Infants & Newborns (0)
Infectious Disease (0)
Kidney & Urinary Tract (0)
Liver (0)
Lung (0)
Men Health (0)
Mental Health & Behavioral Research (0)
Muscle & Bone (0)
Obesity & Weight Management (0)
Pain Control (0)
Poisoning/Injury (0)
Pregnancy and Obstetrics (0)
Sickle Cell (0)
Skin/Dermatology (0)
Sleep Disorders (0)
Tobacco Addiction (0)
Vision/Eye (0)
Women Health (0)
Status
New (0)
IRB Initial Approval (0)
PRC Approval (0)
Project Manager Signoff (0)
Open to Accrual (11)
Closed to Accrual (0)
For Affiliates Only (0)
IRB Study Closure (0)
Age
Select a year
Select a year
Less than 1 year
1 year
2 years
3 years
4 years
5 years
6 years
7 years
8 years
9 years
10 years
11 years
12 years
13 years
14 years
15 years
16 years
17 years
18 years
19 years
20 years
21 years
22 years
23 years
24 years
25 years
26 years
27 years
28 years
29 years
30 years
31 years
32 years
33 years
34 years
35 years
36 years
37 years
38 years
39 years
40 years
41 years
42 years
43 years
44 years
45 years
46 years
47 years
48 years
49 years
50 years
51 years
52 years
53 years
54 years
55 years
56 years
57 years
58 years
59 years
60 years
61 years
62 years
63 years
64 years
65 years
66 years
67 years
68 years
69 years
70 years
71 years
72 years
73 years
74 years
75 years
76 years
77 years
78 years
79 years
80 years
81 years
82 years
83 years
84 years
85 years
86 years
87 years
88 years
89 years
90 years
Search
Profile
Sarah Goldberg
Clear
Search
Showing 11 results
in 'Clinical Trials'
Clinical Trials
Open to Accrual
Sarah Goldberg
Clinical Trial
A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)
Clinical Trial
A Phase III, Double-blind, Placebo-controlled, Randomised, Multicentre, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizumab in Patients With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Definitive, Platinum-Based Concurrent Chemoradiation Therapy
Clinical Trial
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Clinical Trial
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Clinical Trial
Determining Mechanisms of Sensitivity and Resistance to Anti-Cancer Therapy for Advanced Lung Cancer
Clinical Trial
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Clinical Trial
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Clinical Trial
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Clinical Trial
Phase IB/II Trial Of Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
Clinical Trial
Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Clinical Trial
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads
[7640,9243,2243,2317,8261,8480,8766,2324,3053]
{"namedChunks":["modules-page-components-ComponentWrapper","modules-search-components-global-search-GlobalSearchContainer","modules-footer-components-Footer"]}